Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Substance Withdrawal Syndrome × Dasatinib × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Burkitt Lymphoma 7 Leukemia, Myeloid, Chronic-Phase 6 Leukemia 6 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myeloid, Acute 3 Prostatic Neoplasms 2 Philadelphia Chromosome 2 Neoplasms 2 Neoplasm, Residual 2 Lymphoma 2 Hematologic Neoplasms 2 Prostate Cancer Recurrent 1 Primary Myelofibrosis 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mastocytosis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Hypereosinophilic Syndrome 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡